← Leaderboards
Douglas Dewayne Cary
Cary Pharmaceuticals
$337,714
Attributed
$337,714
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$337,714 · 1
By mechanism
R43$337,714 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Drug Addiction Antagonist”
- Sharon L. Walsh · University Of Kentucky$86,899,770
- Maurizio Fava · Massachusetts General Hospital$20,923,302
- Jeffrey Reich · Sparian Biosciences, Inc.$18,033,159
- Nurulain T Zaveri · Sri International$15,081,160
- Paul J Kenny · Icahn School Of Medicine At Mount Sinai$14,024,111
- Alexandros Makriyannis · University Of Connecticut Storrs$13,275,497
Research focus
Drug Addiction AntagonistDrug Adverse EffectDrug Design /Synthesis /ProductionDrug Screening /Evaluation